Abstract:BACKGROUND:Neuropathic pain is still a challenge for clinical treatment as a result of the comprehensive pathogenesis. Although emerging evidence demonstrates the pivotal role of glial cells in regulating neuropathic pain, the role of Schwann cells and their underlying mechanisms still need to be uncovered. Pannexin 1 (Panx 1), an important membrane channel for the release of ATP and inflammatory cytokines, as well as its activation in central glial cells, contributes to pain development. Here, we hypothesized that Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain.METHODS:A mouse model of chronic constriction injury (CCI) in CD1 adult mice or P0-Cre transgenic mice, and in vitro cultured Schwann cells were used. Intrasciatic injection with Panx 1 blockers or the desired virus was used to knock down the expression of Panx 1. Mechanical and thermal sensitivity was assessed using Von Frey and a hot plate assay. The expression of Panx 1 was measured using qPCR, western blotting, and immunofluorescence. The production of cytokines was monitored through qPCR and enzyme-linked immunosorbent assay (ELISA). Panx1 channel activity was detected by ethidium bromide (EB) uptake.RESULTS:CCI induced persistent neuroinflammatory responses and upregulation of Panx 1 in Schwann cells. Intrasciatic injection of Panx 1 blockers, carbenoxolone (CBX), probenecid, and Panx 1 mimetic peptide (10Panx) effectively reduced mechanical and heat hyperalgesia. Probenecid treatment of CCI-induced mice significantly reduced Panx 1 expression in Schwann cells, but not in dorsal root ganglion (DRG). In addition, Panx 1 knockdown in Schwann cells with Panx 1 shRNA-AAV in P0-Cre mice significantly reduced CCI-induced neuropathic pain. To determine whether Schwann cell Panx 1 participates in the regulation of neuroinflammation and contributes to neuropathic pain, we evaluated its effect in LPS-treated Schwann cells. We found that inhibition of Panx 1 via CBX and Panx 1-siRNA effectively attenuated the production of selective cytokines, as well as its mechanism of action being dependent on both Panx 1 channel activity and its expression.CONCLUSION:In this study, we found that CCI-related neuroinflammation correlates with Panx 1 activation in Schwann cells, indicating that inhibition of Panx 1 channels in Schwann cells reduces neuropathic pain through the suppression of neuroinflammatory responses.

Proteomic Identification of an Upregulated Isoform of Annexin A3 in the Spinal Cords of Rats in a Neuropathic Pain Model.

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

Temporal Changes of Spinal Transcriptomic Profiles in Mice With Spinal Nerve Ligation.

Annexin 1 Exerts Anti-Nociceptive Effects after Peripheral Inflammatory Pain Through Formyl-Peptide-receptor-like 1 in Rat Dorsal Root Ganglion

Inhibition of Schwann Cell Pannexin 1 Attenuates Neuropathic Pain Through the Suppression of Inflammatory Responses

Epigenetic Modulation of Wnt Signaling Contributes to Neuropathic Pain in Rats.

Identification of Differentially Expressed Proteins in the Spinal Cord of Neuropathic Pain Models with PKCgamma Silence by Proteomic Analysis

Proteomic analysis of differential proteins related to the neuropathic pain and neuroprotection in the dorsal root ganglion following its chronic compression in rats

Gene Transcript Alterations in the Spinal Cord, Anterior Cingulate Cortex, and Amygdala in Mice Following Peripheral Nerve Injury

Establishment of the proteomics of spinal cord in rats with neuropathic pain

Microglial Annexin A3 Downregulation Alleviates Bone Cancer-Induced Pain Through Inhibiting the Hif-1α/vascular Endothelial Growth Factor Signaling Pathway

Exploring gene signatures and regulatory networks in a rat model of sciatica: implications and validation in neuropathic pain

Down-Regulation of Gap-43 by Inhibition of Caspases-3 in A Rat Model of Neuropathic Pain

Analyses of long non-coding RNA and mRNA profiles in the spinal cord of rats using RNA sequencing during the progression of neuropathic pain in an SNI model

The mechanism of Annexin A1 to modulate TRPV1 and nociception in dorsal root ganglion neurons

Involvement of Spinal Neuroplastin 65 in Neuropathic Pain by GABAA Receptor α2 Subunit Regulation

Genome-wide Analysis of Histone H3 Lysine 27 Trimethylation Profiles in Sciatic Nerve of Chronic Constriction Injury Rats

Expression and distribution of annexin A2 in dorsal root ganglion after chronic compression of dorsal root ganglion in rats

Neuroinflammation Signatures in Dorsal Root Ganglia Following Chronic Constriction Injury

CXCR3 signalling partially contributes to the pathogenesis of neuropathic pain in male rodents

CircAnks1a in the Spinal Cord Regulates Hypersensitivity in a Rodent Model of Neuropathic Pain